SHINGRIX
Total Payments
$6.7M
Transactions
185,942
Doctors
66,535
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.0M | 28,712 | 18,672 |
| 2023 | $1.9M | 48,891 | 27,499 |
| 2022 | $1.8M | 33,812 | 20,549 |
| 2021 | $789,878 | 19,818 | 12,942 |
| 2020 | $260,441 | 11,973 | 7,910 |
| 2019 | $320,291 | 11,086 | 7,338 |
| 2018 | $588,071 | 28,412 | 17,837 |
| 2017 | $97,180 | 3,238 | 3,037 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3.6M | 182,505 | 52.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.3M | 833 | 33.7% |
| Travel and Lodging | $469,301 | 1,423 | 7.0% |
| Consulting Fee | $379,395 | 122 | 5.6% |
| Unspecified | $22,878 | 2 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $18,090 | 16 | 0.3% |
| Education | $11,595 | 1,039 | 0.2% |
| Grant | $2,784 | 2 | 0.0% |
Payments by Type
General
$6.7M
185,940 transactions
Research
$22,878
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 0000000000000000000000000000000000000000000000000000000000000000216948 | GlaxoSmithKline, LLC. | $11,874 | 0 |
| 216948 | GlaxoSmithKline, LLC. | $11,004 | 0 |
Top Doctors Receiving Payments for SHINGRIX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Geriatric Medicine | Laguna Hills, CA | $382,503 | 459 |
| , MD | Family Medicine | Greenwood, IN | $382,371 | 437 |
| , D.O | Family Medicine | Arlington, TX | $310,293 | 348 |
| , M.D | Internal Medicine | Baltimore, MD | $301,004 | 395 |
| , MD | Infectious Disease | Dayton, OH | $270,443 | 193 |
| , M.D | Family Medicine | Los Angeles, CA | $268,528 | 263 |
| , MD | Pediatrics | Los Angeles, CA | $251,223 | 275 |
| , M.D | Infectious Disease | Weymouth, MA | $165,914 | 119 |
| , MD | Family Medicine | Buffalo, NY | $165,611 | 163 |
| , MD PHD | Dermatology | Webster, TX | $84,830 | 59 |
| , MD | Specialist | Omaha, NE | $59,954 | 56 |
| Dean Peyton | — | Azle, TX | $57,904 | 200 |
| , MD | Infectious Disease | Kirkland, WA | $48,319 | 45 |
| , D.O | Internal Medicine | Lansing, MI | $47,699 | 44 |
| , M.D | Internal Medicine | Torrance, CA | $29,075 | 15 |
| , M.D | Internal Medicine | Rochester, MN | $27,047 | 17 |
| , MD | Infectious Disease | Portland, OR | $24,876 | 11 |
| , MD | Family Medicine | Latham, NY | $23,861 | 30 |
| , DO | Rheumatology | Cleveland, OH | $19,322 | 13 |
| , M.D | Endocrinology, Diabetes & Metabolism | Philadelphia, PA | $17,020 | 2 |
| , MD | Emergency Medicine | Stanford, CA | $14,583 | 2 |
| , MD | Pediatrics | Del Mar, CA | $12,500 | 1 |
| , M.D | Hematology & Oncology | Durham, NC | $12,415 | 3 |
| Susan Hill | Family Medicine | Leesburg, FL | $12,346 | 3 |
| , M.D | Neurology | East Setauket, NY | $10,560 | 6 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $6.7M
Product Information
- Type Drug
- Total Payments $6.7M
- Total Doctors 66,535
- Transactions 185,942
About SHINGRIX
SHINGRIX is a drug associated with $6.7M in payments to 66,535 healthcare providers, recorded across 185,942 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2017 to 2024. In 2024, $1.0M was paid across 28,712 transactions to 18,672 doctors.
The most common payment nature for SHINGRIX is "Food and Beverage" ($3.6M, 52.9% of total).
SHINGRIX is associated with 2 research studies, including "0000000000000000000000000000000000000000000000000000000000000000216948" ($11,874).